CC
TERN

Centiva Capital’s Terns Pharmaceuticals TERN Stock Holding History

Centiva Capital’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,100
Closed -$5.91M – 2201
2026
Q1 		$5.91M Buy
+112,100
New +$4.6M 0.04% 253

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Centiva Capital's TERN Position: Q2 2026 in Review

Centiva Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 101,225 shares — an estimated $5.34M sold.

Centiva Capital first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $5.34M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Centiva Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 101,225 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.34M.
  • Centiva Capital first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Centiva Capital's Terns Pharmaceuticals position peaked at $5.34M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.